Pharmacogenomic (PGx) Testing Service
Description: The project wishes to appoint a suitable laboratory or multiple labs to supply an end-to-end genomic testing service which provides genomic variant data for n=4,854 participants in Northern Ireland (NI) and Ireland. Specifically, the areas where the project will recruit participants from of relevance to this tender includes counties Londonderry, Tyrone in Northern Ireland and counties Donegal and Sligo in Ireland. The iMPROVE project will operate on the basis of a research implementation study which aims to integrate pharmacogenomic testing into a patient-centred medicines optimisation care pathway in GP practices across the project regions. The new integrated care pathway will be led by GP practice pharmacists with a focus on medicines optimisation to improve outcomes, removing inappropriate and ineffective treatments and adverse drug event risk reduction. Medications for (read more...)
Summary: Ulster University is currently in the tender stage of a procurement process for a Pharmacogenomic (PGx) Testing Service. This initiative involves procuring laboratory services for genomic testing of 4,854 participants across Northern Ireland and Ireland, including Counties Londonderry, Tyrone, Donegal, and Sligo. The project is part of the iMPROVE study aimed at integrating pharmacogenomic testing into patient-centred GP practices. The process follows an open procurement method, and the deadline for tender submissions is set for 24th June 2026, with the contract planned to commence on 3rd August 2026, running initially until August 2028. The procurement is governed by Northern Irish devolved regulations with a focus on providing services that span miscellaneous health services, medical laboratory, and analysis services.